Michael D. Witzeman is President & VP +1 at CHEMED CORP (CHE). They have made 13 open-market trades across 1 company since 2017, most recently 2026-02-13.
CIK 0001699624
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CHE | 6,073 | $3.3M |
Shares reported on the most recent Form 4, priced at the 2026-02-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHE | SELL | 2024-03-21 | 2024-03-22 | $643.14 | $1.7M | -2.9% | -6.8% | -17.7% |
| CHE | SELL | 2022-11-10 | 2022-11-14 | $498.47 | $734K | +4.7% | +5.0% | +1.7% |
| CHE | SELL | 2022-11-03 | 2022-11-04 | $482.62 | $627K | +3.6% | +8.6% | +7.2% |
| CHE | SELL | 2020-12-17 | 2020-12-18 | $520.00 | $1.3M | -0.6% | -0.7% | -15.6% |
| CHE | SELL | 2020-11-04 | 2020-11-05 | $514.73 | $515K | -4.1% | -5.7% | +1.9% |
| CHE | SELL | 2020-08-03 | 2020-08-03 | $500.00 | $1.0M | +2.0% | +5.1% | -3.3% |
| CHE | SELL | 2019-12-04 | 2019-12-05 | $435.00 | $1.1M | +0.6% | +2.3% | +2.7% |
| CHE | SELL | 2019-08-16 | 2019-08-19 | $432.50 | $1.9M | -1.2% | -2.0% | -4.1% |
| CHE | SELL | 2019-03-12 | 2019-03-13 | $328.00 | $241K | -1.3% | -0.5% | +6.2% |
| CHE | SELL | 2018-08-24 | 2018-08-24 | $322.00 | $549K | -2.0% | -2.6% | -6.9% |
| CHE | SELL | 2018-05-02 | 2018-05-04 | $313.00 | $313K | +4.8% | +4.2% | +0.8% |
| CHE | SELL | 2017-12-04 | 2017-12-04 | $250.00 | $250K | -3.2% | +2.3% | +9.8% |
| CHE | SELL | 2017-11-16 | 2017-11-17 | $235.00 | $371K | +6.3% | +3.3% | +10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.